News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
168 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Drug Development
Investors Elated as Vertex Picks Two Top CF Triple Combos for Phase III Trials
Vertex is keeping its promise of advancing triple combination treatments for patients with cystic fibrosis and investors are happy.
February 1, 2018
·
2 min read
·
Alex Keown
Deals
Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi
Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi.
February 1, 2018
·
2 min read
·
Mark Terry
Policy
3 FDA Decisions to Look Out for in February
Here is a look at a few important regulatory events scheduled for the month of February.
February 1, 2018
·
2 min read
·
Mark Terry
Genetown
Mysterious Biotech Unicorn Moderna Nabs Another $500M, Is Now Worth $7B
One can only hope that Moderna Therapeutics can live up to the hype, both scientifically and financially.
February 1, 2018
·
3 min read
·
Mark Terry
Business
Stada Names Novartis Exec as New CEO, It’s Fifth Leader Since 2016
Today STADA announced the appointment of Peter Goldschmidt as new CEO and chairman of the board.
February 1, 2018
·
2 min read
·
Mark Terry
Policy
Booming Celltrion Falls After FDA Warning Letter
Celltrion are down more than 5 percent after the company announced it received a warning letter from the FDA after the regulatory agency inspected a company drug manufacturing facility.
February 1, 2018
·
2 min read
·
Alex Keown
Biotech Beach
Cianna Medical: Making Breast Cancer Surgery Easier for Women: Over 25,000 Women in U.S. Experienced Wire-free Breast Tumor Localization With SAVI SCOUT
SCOUT is the most precise and broadly applicable localizing system available.
February 1, 2018
·
3 min read
Drug Development
Roche Throws in the Towel on a Host of Early, Late-Stage Drug Candidates
Along with lampalizumab, Roche announced it was culling several drug programs in its latest financial filing.
February 1, 2018
·
2 min read
·
Alex Keown
Business
Trump’s CDC Director Resigns Over Pharma, Tobacco Investments
Fitzgerald resigns four months after ex-HHS Secretary Price.
February 1, 2018
·
1 min read
Business
Medtronic’s 7% Miracle
The company goes “above and beyond” with staggering 7% or greater dividend raises over 25 years.
February 1, 2018
·
1 min read
1 of 17
Next